Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease (Q46871449)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease |
scientific article published in January 2006 |
Statements
1 reference
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease (English)
1 reference
K Rajender Reddy
1 reference
Norah A Terrault
1 reference
Rolland C Dickson
1 reference
Michael Ishitani
1 reference
Patricia Sheiner
1 reference
Velimir Luketic
1 reference
Consuelo Soldevila-Pico
1 reference
Michael Fried
1 reference
Donald Jensen
1 reference
Robert S Brown
1 reference
Gary Horwith
1 reference
Richard Brundage
1 reference
Anna Lok
1 reference
1 January 2006
1 reference
1 reference
12
1 reference
1
1 reference
124-133
1 reference
Identifiers
1 reference
1 reference